Observational studyCurrent Alzheimer research2026
Relation between Cerebrospinal Fluid Catecholamines and Vascular Risk Factors, Thyroid Function and Vitamins in Healthy Individuals and Patients with Neurodegenerative Diseases.
Observational study in Current Alzheimer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe locus coeruleus is the primary site of norepinephrine (NE) synthesis in the brain. Its dysfunction has been implicated in the pathogenesis of Alzheimer's disease. Vascular risk factors, thyroid dysfunction, and vitamin deficiencies have also been associated with an increased risk of dementia. This study aimed to evaluate the relationship between the catecholaminergic system-by measuring cerebrospinal fluid (CSF) levels of L-3,4-dihydroxyphenylalanine (L-DOPA), dopamine (DA), and NE-and vascular risk factors, thyroid dysfunction, and vitamin deficiencies.
methodsWe conducted a cross-sectional observational study in which CSF levels of L-DOPA, DA and NE were measured in 117 participants. Data on Blood Pressure (BP), heart rate, glycaemic and lipid profiles, smoking history, thyroid function and vitamin B12 and folic acid levels were collected for each participant.
resultsWe found significant correlations between NE and CSF glucose levels (r = 0.308, p = 0.003) in participants without diabetes mellitus, between L-DOPA and orthostatic variation of diastolic BP (r = -0.288, p = 0.014) and high-density lipoprotein (r = 0.404, p = 0.001) and between NE and triglycerides (r = 0.271, p = 0.030) and folic acid (r = 0.298, p = 0.009). DISCUSSION: This is the first study to demonstrate correlations between CSF NE levels and CSF glucose, probably due to the effect of NE on astrocytes, and between CSF NE levels and folic acid, possibly related to its role in catecholamine synthesis. CSF L-DOPA levels were correlated with cardiovascular risk factors such as the orthostatic regulation of diastolic BP.
conclusionThese findings may contribute to a better understanding of the pathophysiology of neurodegenerative diseases.
Indexed as
Identifiers
41486994What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.